Market Cap:
$ SEC Filings
| Filing | Filed On |
|---|---|
| POST-EFFECTIVE AMENDMENT TO S-3 | 30 Aug 2012 |
| FORM 8-K | 20 Aug 2012 |
| REGISTRATION STATEMENT | 15 Aug 2012 |
| FORM 10-Q | 09 Aug 2012 |
| FORM 8-K | 07 Aug 2012 |
| FORM 8-K | 06 Aug 2012 |
| FORM 8-K | 31 Jul 2012 |
| PLATINUM PARTNERS VALUE ARBITAGE FUND SC 13G 4-2-2012 | 27 Jul 2012 |
| AUTO-GENERATED PAPER DOCUMENT | 11 Jul 2012 |
| FORM DEF 14A | 10 Jul 2012 |
| FORM 8-K | 07 Jun 2012 |
| PLATINUM-MONTAUR LIFE SCIENCES, LLC SC 13DA #2 4-2-2012 (NAVIDEA BIOPHARMACEUTIC | 04 Jun 2012 |
| FORM 10-Q | 10 May 2012 |
| FORM 8-K | 03 May 2012 |
| 4 | 23 Apr 2012 |
| 4 | 23 Apr 2012 |
| FORM 8-K | 23 Apr 2012 |
| 4 | 23 Apr 2012 |
| CT ORDER | 13 Apr 2012 |
| CURRENT REPORT | 13 Apr 2012 |
